Remote Exercise SWEDEHEART Study

NCT ID: NCT04260958

Last Updated: 2024-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-03

Study Completion Date

2028-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall aim of the study is to evaluate if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase participation in exCR sessions post myocardial infarction (MI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Due to the covid-19 pandemic, this study will be performed in two steps:

1). National feasibility and safety study. 2). National multicenter registry-based cluster randomized crossover clinical trial (RRCT).

1. In the feasibility study, patients will be offered remote exCR at all participating sites until the peak of the pandemic has been achieved and care goes back to normal. The feasibility study will include patients until Aug 2022.
2. CR centers (not patients) will be cluster randomized to either the intervention or control. Patients at intervention centers will be offered remote exCR, usual care centre-based exCR, or a combination of both modes, as self-preferred choice. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be 15 months. Long-term follow-up will be performed 1 year and 3 years after the index cardiac event.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Exercise-based cardiac rehabilitation Secondary prevention EHealth Telerehabilitation Physical fitness Health-related quality of life cost-effectiveness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

CR centers will be cluster randomized and start as either the intervention or control center. Patients at intervention centers will be offered remote video exCR (first-hand option), usual care centre-based exCR or a combination of these two exercise modes. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be 15 months and then cross-over will occur, so that intervention centers become control centers and the other way around. At intervention centers, patients participating in remote exCR will finish their 3-month exercise period, but no new patients will be offered remote exCR after the cross-over has occurred.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention center

Patients at intervention centers will be offered remote video exCR (first-hand option), usual care centre-based exCR or a combination. The exercise program (remote/centre-based) will be standardized and performed for totally 60 minutes, 2 times a week for 3 months. Exercise will be individually prescribed and progressed by physiotherapists in accordance with guidelines. Patients will also be asked to perform one additional session of at least 30 min aerobic exercise per week, at intensity level 13-15 according to Borg RPE-scale.

Group Type EXPERIMENTAL

Exercise-based cardiac rehabilitation

Intervention Type OTHER

The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.

Control

At control centers, patients will be offered usual care centre-based exCR only. Patients will also be asked to perform one additional session of at least 30 min aerobic exercise per week, at intensity level 13-15 according to Borg RPE-scale.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise-based cardiac rehabilitation

The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent
* Diagnosis of type 1 myocardial infarction (AMI)
* Age 18-79 years at discharge from hospital

Exclusion Criteria

* Patients with incomplete coronary revascularization defined as at least one remaining hemodynamically significant stenosis
* Severe valve or structural heart disease
* Severe heart failure (NYHA III - IV)
* Serious arrythmias
* Inability to understand Swedish
* No internet access at home (only applicable for patients in the intervention group who wants to perform remote exCR)
* Pathological exercise test indicating high risk for adverse events during exCR
* More than 6 months between discharge form hospital and screening
* Any other condition that may interfere with the possibility for the patient to comply with the study protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sahlgrenska University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maria Bäck

Associate professor, physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Back, Ass Prof

Role: PRINCIPAL_INVESTIGATOR

Sahlgrenska University Hospital

Stefan James, Prof

Role: STUDY_CHAIR

Uppsala Clinial Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Södra Älvsborg Hospital

Borås, , Sweden

Site Status RECRUITING

Mälarsjukhuset

Eskilstuna, , Sweden

Site Status RECRUITING

Falun hospital

Falun, , Sweden

Site Status RECRUITING

Gällivare Hospital

Gällivare, , Sweden

Site Status RECRUITING

Gävle Hospital

Gävle, , Sweden

Site Status RECRUITING

Angered Hospital

Gothenburg, , Sweden

Site Status RECRUITING

Sahlgrenska University Hospital Östra

Gothenburg, , Sweden

Site Status RECRUITING

Sahlgrenska University Hospital

Gothenburg, , Sweden

Site Status RECRUITING

Hässleholm Hospital

Hässleholm, , Sweden

Site Status RECRUITING

Jönköping Ryhov hospital

Jönköping, , Sweden

Site Status RECRUITING

Kalix hospital

Kalix, , Sweden

Site Status RECRUITING

Kalmar Hospital

Kalmar, , Sweden

Site Status RECRUITING

Kungälv Hospital

Kungälv, , Sweden

Site Status RECRUITING

Lindesberg Hospital

Lindesberg, , Sweden

Site Status RECRUITING

Linköping University Hospital

Linköping, , Sweden

Site Status RECRUITING

Ljungby Hospital

Ljungby, , Sweden

Site Status RECRUITING

Sunderbyn hospital

Luleå, , Sweden

Site Status RECRUITING

Skåne University hospital

Lund, , Sweden

Site Status RECRUITING

Skåne University Hospital Malmö

Malmo, , Sweden

Site Status RECRUITING

Östersund hospital

Östersund, , Sweden

Site Status RECRUITING

Södertälje Hospital

Södertälje, , Sweden

Site Status RECRUITING

Capio St Göran Hospital

Stockholm, , Sweden

Site Status RECRUITING

Karolinska University Hospital

Stockholm, , Sweden

Site Status RECRUITING

Sundsvall hospital

Sundsvall, , Sweden

Site Status RECRUITING

Uppsala University Hopsital

Uppsala, , Sweden

Site Status RECRUITING

Värnamo hospital

Värnamo, , Sweden

Site Status TERMINATED

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maria Back, Ass Prof

Role: CONTACT

Phone: +46700895612

Email: [email protected]

Elisabeth Palmcrantz Graf

Role: CONTACT

Phone: +46186119542

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ellinor Nylund, RPT

Role: primary

Ellinor Nylund, RPT

Role: backup

Annalina Anduri Ohlsson, RPT

Role: primary

Lovisa Wahlen, RPT

Role: primary

Lovisa Wahlen, RPT

Role: backup

Sara Fabricius, RPT

Role: primary

Anna Forsgren, RPT

Role: primary

Aziza Ferreira, RPT

Role: primary

Klara Emanuelsson Hummel, RPT

Role: primary

Maria Bäck, PhD

Role: primary

Maria Back, Ass Prof

Role: backup

Sandra Larsson, RPT

Role: primary

Maria Sahlin, RPT

Role: primary

Maria Sahlin, RPT

Role: backup

Eva Öberg, RPT

Role: primary

Eva Öberg, RPT

Role: backup

Charlotta Lans, PhD

Role: primary

Tina Nyth Persson, RPT

Role: primary

Marcus Bargholtz, MSc

Role: primary

Sabina Borg, RPT

Role: primary

Sabina Borg, RPT

Role: backup

Jessica Olovsson, RPT

Role: primary

Lena Bergström, RPT

Role: primary

Lena Bergström, RPT

Role: backup

Simon Holm, RPT

Role: primary

Simon Holm, RPT

Role: backup

Margret Leosdottir, PhD

Role: primary

Mattias Pettersson, RPT

Role: primary

Mattias Pettersson, RPT

Role: backup

Maria Jäderlund, MSc

Role: primary

Sofia Haghanipour, RPT

Role: primary

Amanda Lönn, PhD

Role: primary

Annika Henriksson

Role: primary

Kajsa Hedin

Role: backup

Charlotte Urell, PhD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Back M, Leosdottir M, Ekstrom M, Hambraeus K, Ravn-Fischer A, Oberg B, Ostlund O, James S. The remote exercise SWEDEHEART study-Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT). Am Heart J. 2023 Aug;262:110-118. doi: 10.1016/j.ahj.2023.04.014. Epub 2023 Apr 25.

Reference Type BACKGROUND
PMID: 37105430 (View on PubMed)

Back M, Leosdottir M, Ekstrom M, Hambraeus K, Ravn-Fischer A, Borg S, Brosved M, Flink M, Hedin K, Lans C, Olovsson J, Urell C, Oberg B, James S. Feasibility, safety and patient perceptions of exercise-based cardiac telerehabilitation in a multicentre real-world setting after myocardial infarction-the remote exercise SWEDEHEART study. Eur Heart J Digit Health. 2025 Mar 4;6(3):508-518. doi: 10.1093/ehjdh/ztaf014. eCollection 2025 May.

Reference Type DERIVED
PMID: 40395424 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U-2018-312

Identifier Type: -

Identifier Source: org_study_id